We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+13.3%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$463M
AUM Growth
+$326M
Cap. Flow
+$324M
Cap. Flow %
69.94%
Top 10 Hldgs %
8.1%
Holding
694
New
390
Increased
110
Reduced
28
Closed
165

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$5.03M
2
NKE icon
Nike
NKE
+$4.85M
3
WMT icon
Walmart Inc
WMT
+$4.79M
4
TRU icon
TransUnion
TRU
+$3.45M
5
ODFL icon
Old Dominion Freight Line
ODFL
+$3.4M

Top Sells

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$2.99M
2
LHX icon
L3Harris
LHX
+$2.1M
3
XLNX
Xilinx Inc
XLNX
+$1.93M
4
CLGX
Corelogic, Inc.
CLGX
+$1.83M
5
BABA icon
Alibaba
BABA
+$1.51M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.69%
2 Technology 15.79%
3 Healthcare 14.21%
4 Industrials 12.25%
5 Financials 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YUMC icon
476
Yum China
YUMC
$16.3B
$259K 0.06%
+4,900
New +$259K
BERY
477
DELISTED
Berry Global Group, Inc.
BERY
$256K 0.06%
+5,772
New +$265K
OGS icon
478
ONE Gas
OGS
$5.04B
$255K 0.06%
3,700
-1,400
-27% -$103K
WPM icon
479
Wheaton Precious Metals
WPM
$60.9B
$255K 0.06%
+5,200
New +$265K
NVAX icon
480
Novavax
NVAX
$1.31B
$254K 0.05%
+2,340
New +$285K
SPCE icon
481
Virgin Galactic
SPCE
$398M
$253K 0.05%
+658
New +$250K
EVTC icon
482
Evertec
EVTC
$1.78B
$250K 0.05%
+7,200
New +$232K
ZTS icon
483
Zoetis
ZTS
$30.5B
$248K 0.05%
+1,500
New +$231K
SGMO
484
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$247K 0.05%
+26,155
New +$283K
SE icon
485
Sea Limited
SE
$69.5B
$246K 0.05%
1,596
-2,004
-56% -$270K
PEGA icon
486
Pegasystems
PEGA
$5.38B
$244K 0.05%
4,030
-2,970
-42% -$171K
GDOT icon
487
Green Dot
GDOT
$745M
$243K 0.05%
+4,800
New +$246K
SMG icon
488
ScottsMiracle-Gro
SMG
$3.66B
$241K 0.05%
+1,579
New +$244K
DUK icon
489
Duke Energy
DUK
$97.3B
$239K 0.05%
+2,700
New +$223K
SRPT icon
490
Sarepta Therapeutics
SRPT
$1.77B
$239K 0.05%
+1,700
New +$258K
DINO icon
491
HF Sinclair
DINO
$14.5B
$238K 0.05%
+12,100
New +$301K
EG icon
492
Everest Group
EG
$14.4B
$237K 0.05%
1,200
EV
493
DELISTED
Eaton Vance Corp.
EV
$237K 0.05%
6,200
-5,000
-45% -$191K
INO icon
494
Inovio Pharmaceuticals
INO
$69M
$233K 0.05%
+1,672
New +$349K
LOPE icon
495
Grand Canyon Education
LOPE
$3.98B
$232K 0.05%
2,900
-700
-19% -$63.4K
SWBI icon
496
Smith & Wesson
SWBI
$637M
$232K 0.05%
+14,940
New +$264K
AN icon
497
AutoNation
AN
$6.92B
$228K 0.05%
+4,317
New +$225K
CHL
498
DELISTED
China Mobile Limited
CHL
$228K 0.05%
+7,100
New +$249K
ALLE icon
499
Allegion
ALLE
$14.4B
$227K 0.05%
+2,300
New +$233K
CLR
500
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$227K 0.05%
+18,513
New +$301K

Similar funds

Seven Eight Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Seven Eight Capital held 694 positions worth $463M, up 239% from $137M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Seven Eight Capital deployed $324M of net new capital in Q3 2020, opening 390 new positions and adding to 110 existing holdings. Its largest new stake was Nike: 45,200 shares worth $5.67M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Xilinx Inc, an estimated $1.93M trimmed.

  • Seven Eight Capital's largest Q3 2020 buy was Nike: 45,200 shares worth $5.67M.
  • Seven Eight Capital added most to Cigna in Q3 2020, an estimated $5.03M increase.
  • Seven Eight Capital's biggest Q3 2020 reduction was Xilinx Inc, cutting an estimated $1.93M.
  • Seven Eight Capital fully exited Conagra Brands in Q3 2020, selling an estimated $2.99M.
  • Seven Eight Capital's ten largest holdings make up 8.1% of its $463M portfolio in Q3 2020.
  • Seven Eight Capital opened 390 new positions and closed 165 in Q3 2020.
  • Seven Eight Capital's portfolio value rose 239% quarter-over-quarter to $463M.

Based on Seven Eight Capital's 13F filing for Q3 2020, filed 16 Nov 2020.